A positive 8-0 vote at the FDA paves the way for first implanted CGM to come to the US; read what patient advocates and healthcare providers like about Eversense!

The results were so positive it was deemed unethical to keep giving people placebo instead of Invokana, an SGLT-2 inhibitor approved for type 2 diabetes

FDA clearance and limited US launch expected in the second half of 2018. Dash adds improved user experience, Bluetooth, smartphone viewing, remote monitoring

Admelog will launch this year as the first approved biosimilar rapid-acting insulin. Will it be less expensive than Humalog?

A restaurant mistake and four lessons I’m taking away from it…

How you can get a copy of Bright Spots & Landmines: The Diabetes Guide I Wish Someone Had Handed Me.

Google’s health arm Verily/Alcon has announced that its project to develop a glucose-sensing contact lens has been put on hold

Results from the CREDENCE trial suggest that Invokana’s kidney benefits exist on top of blood pressure lowering medications (standard of care)

Xeris’ Glucagon Rescue Pen, designed as an auto-injector, features a ready-to-use liquid glucagon – a safer and more convenient treatment option for severe hypoglycemia

Heart benefits of the SGLT-2 inhibitor pill beyond blood sugars and weight loss for people with type 2 diabetes

The study aims to enroll about 1,800 adults with type 2 diabetes at increased risk of heart disease

CGM accuracy, meal timing, n ew partnerships in diabetes tech, vitamin D for prediabetes, and more!

Surprising study findings from a look at refrigerator temperatures and the risk posed to insulin quality; plus, a guide to safe insulin storage and Med Angel’s very cool...

Called “Insulin Lispro,” the generic version of Humalog may benefit those paying cash or with high-deductible health plans

News from Onduo's virtual diabetes clinic, Klue, SugarMate, and Diabits apps, Tidepool Loop, and more!

The importance of sleep for teens with diabetes. Plus, key sleep strategies from young adults living with diabetes!

New product details, pictures, and study timing updates on Beta Bionics’ iLet and Bigfoot’s Loop and Inject systems from Friends for Life 2018

Data on type 2 diabetes therapies and prevention, Medtronic MiniMed 780G trial starts, Beta Bionics Gen 3 iLet time-in-range results, and more!

Control-IQ hybrid closed loop coming in summer 2019; paired app coming soon to the US; plans for the t:sport “patch” pump; and t:slim X2 pump launched outside the US

Updates to the Clarity app allow G5 and G6 CGM users to set a daily time-in-range goal and be notified when it is reached, awesome Bright Spots pattern recognition in...